What we are studying
Non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) are rare tumors and little is known about them. At the present time, doctors do not always know what the best treatment will be for a subject with one of these tumors. Studies done in both children and adults with NRSTS have shown that the amount of treatment a subject needs may be based on the “risk group” of the tumor.
This study is being done to find out: if treatment based on each subject’s level of risk will get rid of the tumor and if lessening the treatment for lower risk subjects will decrease the side effects of treatment and still get rid of the tumor.